ClinicalTrials.gov
public full text
Public Domain
Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery#909143
- Diabetic Retinopathy Assessed by Ultra-wide#912671
- Therapeutic landscape for diabetic macular edema: durable strategies with a focus on aflibercept 8 mg#681888
- Triglyceride–Glucose Indexes Are Predictive of Early and Severe Diabetic Retinal Microvascular Abnormalities: A Prospective Cohort Study.#227978
- Aflibercept with and without laser therapy in diabetic macular edema: a systematic review and meta-analysis#353652
Record · ID 208352
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive